Pfizer Balance Sheet
- Market cap
- ₹17,426 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹2,742.62 – ₹5,142.42
As of FY25, Pfizer had total assets of ₹11,327 crore and borrowings of ₹2,091 crore, against shareholders' equity of ₹7,962 crore — a debt-to-equity ratio of 0.35.
Pfizer balance sheet
As at each financial year end, newest first. H1 = half-year.
| Item | FY25 |
|---|---|
| Equity capital | 120 |
| Reserves | 7,842 |
| Borrowings | 2,091 |
| Other liabilities | 1,394 |
| Total liabilities | 11,327 |
| Fixed assets | 6,099 |
| Capital work in progress | 45 |
| Investments | 2,614 |
| Other assets | 2,614 |
| Total assets | 11,327 |
Balance sheet ratios
- Debt to equity
- 0.35
- Book value per share
- ₹1,336.56
Source: Company filings (consolidated), in ₹ crore. Data as of 9 October 2026. How this data is compiled.
Pfizer balance sheet — frequently asked questions
What is the total debt of Pfizer?
Pfizer reported borrowings of ₹2,091 crore as of FY25.
What is Pfizer's debt-to-equity ratio?
Based on the FY25 balance sheet, Pfizer's debt-to-equity ratio is 0.35 — borrowings of ₹2,091 crore against equity capital and reserves of ₹7,962 crore.
What are Pfizer's total assets?
Pfizer's total assets were ₹11,327 crore as of FY25, including fixed assets of ₹6,099 crore and investments of ₹2,614 crore.
What is the book value per share of Pfizer?
The book value per share of Pfizer is ₹1,336.56, based on the latest reported balance sheet.
Same Data For Peers
Trade Pfizer With ATS
Track PFIZER live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.